CN Patent

CN105228627B — 亮氨酸和烟酸降低脂质水平

Assigned to Nusirt Sciences Inc · Expires 2018-07-13 · 8y expired

What this patent protects

本文提供了可用于治疗高脂血病况的组合物、方法和试剂盒。这样的组合物可以含有与亮氨酸和/或亮氨酸代谢物组合的协同量的烟酸、烟酰胺核苷和/或烟酸代谢物，含有或不含白藜芦醇。

USPTO Abstract

本文提供了可用于治疗高脂血病况的组合物、方法和试剂盒。这样的组合物可以含有与亮氨酸和/或亮氨酸代谢物组合的协同量的烟酸、烟酰胺核苷和/或烟酸代谢物，含有或不含白藜芦醇。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN105228627B
Jurisdiction: CN
Classification: —
Expires: 2018-07-13
Drug substance claim: No
Drug product claim: No
Assignee: Nusirt Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.